Mr. Louie Canitano reports
MEDX NAMES LOUIE CANITANO AS PRESIDENT AND CHIEF OPERATING OFFICER
MedX Health Corp.'s board of directors has appointed Louie Canitano as president and chief operating officer
effective immediately.
In his new role as president and chief operating officer Mr. Canitano will oversee all operational, financial
and corporate aspects of the company and will focus on executing the strategic plan approved by the board.
MedX's patented medical device technology for the early detection of skin cancer is the company's leading
product and as such will be the focal point of its development and marketing strategy. This product has the
potential to create a new and substantial revenue stream for MedX.
Mr. Canitano joined MedX in February, 2010, as executive vice-president, operations. He has a deep
understanding of operating emerging growth medical device technology companies, and brings to MedX over
18 years of operational medical device experience focusing on engineering, proprietary intellectual property,
management and corporate assignments. Mr. Canitano is uniquely suited to anticipate trends and quickly
respond to regulatory changes and financing challenges, and has experience in all sectors including sales and
marketing, regulatory, IP, design and development, and also holds a patent surrounding laser therapy. Mr.
Canitano began his career with managing G code and Schedule 5-based OHIP physiotherapy and multidisciplinary clinics, introducing and utilizing laser therapy as a palliative modality. He has a bachelor of
sciences in natural health sciences.
Mr. Canitano states: "Skin cancer represents the fastest growing form of cancer in the world and affects all age
groups. Detecting skin cancer early is the key to long-term survival rates and therefore MedX will seek unique
strategic relationships that give ease of access to our technology. This includes partnering with thought leaders,
advocacy partners, and strategic channel partners to ensure our technology has global reach."
We seek Safe Harbor.
© 2025 Canjex Publishing Ltd. All rights reserved.